Eledon Pharmaceuticals, Inc. (ELDN)
NASDAQ: ELDN · Real-Time Price · USD
2.780
+0.160 (6.11%)
At close: Mar 6, 2026, 4:00 PM EST
2.860
+0.080 (2.88%)
After-hours: Mar 6, 2026, 7:57 PM EST
Eledon Pharmaceuticals Employees
Eledon Pharmaceuticals had 31 employees as of December 31, 2024. The number of employees increased by 11 or 55.00% compared to the previous year.
Employees
31
Change (1Y)
11
Growth (1Y)
55.00%
Revenue / Employee
n/a
Profits / Employee
-$2,666,742
Market Cap
220.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Humacyte | 220 |
| Protalix BioTherapeutics | 213 |
| Arcturus Therapeutics Holdings | 176 |
| Voyager Therapeutics | 172 |
| Cibus | 159 |
| MediWound | 111 |
| Alector | 103 |
| Keros Therapeutics | 82 |
ELDN News
- 3 days ago - Eledon Pharmaceuticals to Participate in Leerink Partners 2026 Global Healthcare Conference - GlobeNewsWire
- 4 weeks ago - Eledon Pharmaceuticals to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire
- 6 weeks ago - Eledon Pharmaceuticals Presents Long-Term Phase 1b Data for Tegoprubart in Kidney Transplant Patients at the American Society of Transplant Surgeons Winter Symposium - GlobeNewsWire
- 2 months ago - Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2026 Outlook - GlobeNewsWire
- 3 months ago - Eledon Pharmaceuticals to Participate in the 37th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 3 months ago - Eledon Reports Preliminary Data from First Six Patients with Type 1 Diabetes Treated with Tegoprubart as the Core Immunosuppressant Following Islet Transplantation in Investigator-Initiated Trial at UChicago Medicine - GlobeNewsWire
- 3 months ago - Eledon Pharmaceuticals, Inc. (ELDN) Presents at Guggenheim Securities 2nd Annual Healthcare Innovation Conference Transcript - Seeking Alpha
- 4 months ago - Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2025 Financial Results - GlobeNewsWire